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Abstract
Objectives To provide estimates of the prevalence of chronic conditions in Swiss primary care.
Methods In total, 175 general practitioners (GP) or pediatricians (PED) reporting to the Swiss Sentinel Surveillance
Network collected morbidity data.
Results In 26,853 patient contacts, mean (± SD) age was 55.8 ± 21.6 or 6.1 ± 5.7 years (in GPs vs. PEDs, respectively)
and 47% were males. In GP patients, median Thurgau Morbidity Index was 2 (IQR 1–3). The median numbers of chronic
conditions and permanently used prescribed drugs were 2 (0–5) and 2 (1–4), respectively; in PEDs medians were 0. Out of
all patients, 16.7 and 7.0% of the PED patients were hospitalized during the previous year; patients cared by family/proxies
or community nurses were hospitalized significantly more often than patients living in homes (50.1 vs. 35.4%, OR 1.41,
p\ 0.001). Out of patients over 80 years of age, 51.5% were care dependent and 45.5% of the patients over 90 years were
living in homes for the elderly.
Conclusions In a representative sample of Swiss primary care patients, a substantial part shows multimorbidity with a high
prevalence of chronic diseases, multiple drug treatment, and care dependency. These data may serve to be compared with
other patient groups or other primary care systems.
Trial registration www.clinicaltrials.gov NCT0229537, national study registry www.kofam.ch SNCTP000001207.
Keywords Morbidity  Drug treatment  Care dependency  Hospitalization  Primary health care  Switzerland
Introduction
Due to the aging of most societies worldwide, there has
been an increase in the prevalence of chronic conditions
and multimorbidity (Uijen and van de Lisdonk 2008;
Barnett et al. 2012; Prados-Torres et al. 2014). We define
multimorbidity as three or more conditions that accumulate
in one subject, irrespective of whether these conditions are
related or not. This needs to be distinguished from
comorbidities, which refer to conditions related to disor-
ders of primary interest. For example, renal failure,
peripheral neuropathy and retinopathy are comorbidities of
diabetes and thus form a cluster of interdependent condi-
tions (Prados-Torres et al. 2014).
Most of the elderly people with multiple chronic con-
ditions are cared for in primary care. However, there are
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concerns that the system cannot keep pace with the chronic
disease epidemic leading to an inappropriate provision of
care (Bodenheimer et al. 2009). At present, persons with
multimorbidity need to devote a substantial amount of time
for health care visits and disease management. Due to
functional losses and pain, they have to take various
medicines that increase patients’ risk for polypharmacy or
drug interactions (Blozik et al. 2013). Moreover, patients
with multiple chronic conditions are more likely to become
socially isolated, to experience financial difficulties as well
as a loss of life years (Gijsen et al. 2001). The patients’
families and proxies may be involved as informal care
givers and deliver care which poses additional challenges
in terms of time and required resources (Tennstedt et al.
1989; Ha¨usler et al. 2017). Eventually, multimorbidity also
affects the society with regard to higher costs, the need to
provide healthcare facilities and a decrease of patient’s
workforce (Federal Office of Public Health 2015).
Data on the burden of chronic diseases are important to
plan for appropriate health care services for patients with
chronic conditions and multimorbidity in Switzerland and
internationally. However, valid and nationally representa-
tive epidemiologic data about multimorbidity are often
scarce in Switzerland and other countries. In terms of Swiss
inpatient services, there is a solid data basis, whereas data on
outpatient services including primary care where patients
with chronic conditions are primarily cared for are lacking.
Aims
The aim of this study was, therefore, to provide valid and
representative epidemiologic estimates of the prevalence of
chronic conditions and multimorbidity in the Swiss pri-
mary care population.
Methods
Sample
This analysis was based on the data generated by the Swiss
Sentinel Surveillance Network (Sentinella) (Gna¨dinger
et al. 2015). Sentinella is a network of approximately 180
general practitioners (GPs) and pediatricians (PEDs) and
was founded in 1986 in order to survey communicable
diseases in Switzerland (Federal Office of Public Health
2018). Later, other issues related to family medicine were
also investigated in this system. Furthermore, it performs a
denominator analysis twice a year to define its patient
collective. For the present study, the analysis of physician-
to-patient contacts (PPC) was expanded by the collection
of data related to multimorbidity. Each patient who was
consulting a GP or PED practice participating in Sentinella
between March 7th and March 20th, 2015 was included in
the statistical analysis (patients consulting twice, or more
were included for each visit). Patients refusing data trans-
mission to the Sentinella system were excluded from the
analysis. Furthermore, to characterize their practices and to
evaluate potential difficulties with the study methodology,
the Sentinella physicians completed two questionnaires,
one at the beginning and one at the end of the study
(Gna¨dinger et al. 2017).
Written instructions were delivered to the participating
physicians by the Sentinella administration (Appendix A in
Electronic Supplementary Material). Detailed information
on the definitions of the study parameters given to the
physicians is shown in Appendix B in Electronic Supple-
mentary Material. Appendix C in Electronic Supplemen-
tary Material lists frequently asked questions.
Questionnaires
The year of birth and gender were recorded for each
patient. Physicians provided the Thurgau Morbidity Index
(TMI) (Fischer et al. 2007) as the primary indicator for the
prevalence and degree of severity of chronic conditions and
multimorbidity; the TMI increases with the number of
chronic conditions as well as their severity (a detailed
description of the TMI can be found in the Appendix B in
Electronic Supplementary Material). As secondary indica-
tors, we included the number of chronic conditions (irre-
spective of their severity), the number of prescribed drugs
taken regularly, the Evans’ Index (co-morbidity polyphar-
macy score) (Evans et al. 2012), any hospitalization during
the previous twelve months, and care dependency. The
Evans’ Index was calculated by the simple addition of the
numbers of chronic conditions and drugs taken regularly.
Since the physicians completing the questionnaires were
not trained in using a detailed nursing scale to measure care
dependency (Noelker and Browdie 2014), we created a
simple four-point Likert-type scale item (i.e., no care, care
by proxies, by community nurse (CNS), by an institution);
because usually all parents give care to their children, so
logistic regression analysis was restricted to adult
patients[ 20 years. A follow-up visit was defined as a
second or further visit during the fourteen days of data
collection (we could not differentiate between no follow-up
visit or a missing answer since physicians only reported if a
repeat visit occurred).
Assessment of how the study sample
represented Swiss GPs and the target population
For each physician, we assigned the Sentinella coding
number and asked for the specialization as well as the
language. To determine the representativeness of our
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sample, we performed some comparisons: firstly, we com-
pared our records to the data obtained by the NewIndex AG,
Olten (a merger of Swiss trust center organizations
excluding the canton of Vaud) for 2014. Most physicians
are contracted to a trust center; therefore, the data should
reflect a representative sample of Swiss physicians. Sec-
ondly, we compared the Sentinella physician characteristics
(age, gender, specialization) with the dataset of 2014
obtained from the Swiss Medical Association (FMH) in
Berne which includes all Swiss physicians with information
on their specialization. Virtually all physicians working in
Switzerland are members of the FMH. Thirdly, to verify
complete inclusion, we compared our data with those from
an earlier Sentinella fourteen-day analysis (August 2014)
that was limited to the collection of gender and age data.
And finally, to describe the practice size, we received the
number of PPC for 2015 from the Sentinella administration.
Where applicable, our publication follows the general
STROBE guidelines (Equator, the Network 2018) (Ap-
pendix D in Electronic Supplementary Material).
Statistical methods
Values are given as frequencies, mean ± SD or median
[interquartile range (IQR)], depending on the distribution
of the data. Medians were approximated by Hampel. TMI
scales were compared with Wilcoxon rank sum test.
As the numbers of drugs and conditions as well as the
ordinal data level of TMI or care-dependency variables
were not normally distributed, correlation analyses were
performed with Spearman’s Rho. To assess the represen-
tativeness of the patients and participating physicians, we
used unpaired T- or Chi square tests to identify statistically
significant inferences.
To assess the association of multimorbidity with hos-
pitalization, we used the SPSS GENLINMIXED proce-
dure, a procedure that fits generalized linear mixed models.
Clustering of patients was addressed using a mixed binary
logistic regression with the fixed factors of gender, age,
care dependency, number of chronic drug treatments,
number of chronic conditions, and TMI as well as the
physician’s practice number as a random factor. If one item
was missing, the whole record was excluded from the
analysis. For the statistical analyses, we used the software
SPSS 24 (IBM SPSS 2018).
Results
Records
We received 26,853 PPC data records; 27.5% were trans-
mitted electronically and the remaining files as hard copies
by mail. In total, 22,379 records focused on weeks 11 and
12, 2504 on week 13 and 1970 records on weeks 8–10 and
14–26, respectively.
Description of study physicians and comparison
to all Swiss GPs and PEDs
During 2015, 151 practices were registered in the Sen-
tinella system (where a physician’s code does not neces-
sarily correspond to one physician only), corresponding to
193 physicians. Out of the 151 practices, 144 (94.7%)
which corresponds to 180 physicians regularly reported to
the Sentinella system (which means that they announced
PPCs for at least 39 weeks a year). In total, 119 practices
comprised one reporting physician, 19 two, 5 three, and 1
eight, adding up to 180 physicians. From all physicians,
122 (67.8%) were German, 44 French (24.4%) and 14
Italian speaking (7.8%). Further characteristics are listed in
Table 1 which also provides comparative information with
FMH data on all Swiss physicians. For the statistical
analyses, two practices (5 GPs) regularly to the Sentinella
system were excluded as they did not participate this
denominator analysis. This led to a study sample of 142
practices and 175 physicians.
Response rate and difficulties in variable coding
During 2015, the mean of PPC was 4456 ± 2137 for GPs,
and 5297 ± 2715 for PEDs. Figure e1 (Appendix E in
Electronic Supplementary Material) summarizes the
response rates of the different questionnaire items. Out of
20,799 records concerning adult patients ([ 19 year), all
variables (age, gender, number of conditions and drugs,
TMI, care dependency, and previous hospitalization) were
coded in 18,297 cases (88.0%). As a measure of com-
pleteness of reporting 2 weeks of morbidity data, we
assumed that a proportion of 3.3% or more of the yearly
PPCs would be submitted to our study database; this was
achieved by 161 (92.0%) of the physicians. Items con-
cerning problems of the study physicians with coding of
the morbidity variables are listed in Table e1 (Appendix E
in Electronic Supplementary Material) and the frequently
asked questions in Appendix C in Electronic Supplemen-
tary Material.
Description of patients and comparison to all
patients in Swiss primary care
Out of the 26,853 records, 12,606 could be allocated to
male patients (47.0%), 14,209 to females (52.9%), whereas
for 38 (0.1%) cases information on gender was missing.
Table e2 (Appendix E in Electronic Supplementary Mate-
rial) summarizes the age categories separated by gender
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and compares them with the New Index data for GPs;
Table e3 (Appendix E in Electronic Supplementary Mate-
rial) lists the same information for PEDs. This comparison
demonstrates that the patients consulting the Sentinella
physicians are representative of the overall Swiss primary
care population. A comparison of a fourteen-day analysis
of age and gender from August 2014 with the current data
did not reveal any significant differences of age
(47.2 ± 27.5 vs. 47.5 ± 27.1 years) and gender (47.0 vs.
47.5% males) proportions (2015 vs. 2014, respectively).
Prevalence of chronic disease, multimorbidity,
and polypharmacy
TMI scale values in GP practices were: 0 in 4752 patients
(23.7%), 1 in 3160 (15.7%), 2 in 3972 (19.8%), 3 in 3854
(19.2%), 4 in 2099 (10.5%), 5 in 1537 (7.5%) and 6 in 702
(3.7%) (20,076 valid and 1876 missing recordings). In
PEDs, the results were: 0 in 3711 (85.4%), 1 in 451
(10.4%), 2 in 130 (3.0%), 3 in 23 (0.5%), 4 in 20 (0.5%), 5
in 2 (0.0%), and 6 in 7 (0.2%) patients, respectively (4344
valid and 557 missing recordings). The distribution of TMI
data by age group is shown in Fig. 1. Among the four care-
dependency groups (none, proxies, CNS, nursing home),
TMI values were 1.6, 4.0, 4.1, and 4.3 as estimated by
Hampel. The CNS vs. nursing home group values were not
significantly different (Wilcoxon).
The secondary indicators of multimorbidity showed a
similar pattern. Table e4 (Appendix E in Electronic Sup-
plementary Material) summarizes the morbidity variables
(hospitalization, care dependency, condition and drug
counts, Evans’ Index, TMI, and follow-up visit) by age
categories and gender. The number of chronic conditions in
GP patients was 2 (1–4) (median, interquartile range
[IQR]) and in PEDs 0 (0–0). The spread of chronic con-
ditions is depicted in Figure e2 (Appendix E in Electronic
Supplementary Material). In GP patients, the median
number of prescribed drugs taken regularly was 2 (0–5)
and in PEDs 0 (0–0); the maximum number of regularly
taken drugs was 25 in GPs and 7 in PEDs. Polymedication
([ 4 drugs) was present in 20.7% of the patients, increas-
ing to 60.9% in very elderly (80?) individuals. The dis-
tribution of the number of chronically taken drugs by age is
depicted in Fig. 2. The median value of the Evans Index
was 4 (1–9) in GPs and 0 (0–1) in PEDs; the age distri-
bution is depicted in Figure e3 (Appendix E in Electronic
Supplementary Material).
Hospitalization during the previous year was reported in
3383 of 20,280 records (16.7%) in GPs (1672 missing), and
in 315 of 4481 records (7.0%) in PEDs (420 missing).
Logistic regression (GENLINMIXED procedure) showed
positive and statistically significant associations of hospi-
talization with care dependency, age, number of chronic
drug treatments, number of chronic conditions, and TMI;
females had a weak but not statistically significant negative
association with previous hospitalization (Table 2). The
model showed a negative predictive value of 96.6%, and
positive predictive value of 24.9% for previous hospital-
ization. Outpatients (care-dependency grades 1 and 2) were
statistically significantly more frequently hospitalized than
inpatients living in homes (grade 3) (50.1 vs. 35.4%, OR
1.41, p\ 0.001 by Chi square test); this association
remained statistically significant in the adjusted analysis
(Table 2).
Multiple visits during the fortnight interval were recor-
ded as follows: in GPs 1703 out of 21,022 PPCs (8.2%, 930
records excluded), and in PEDs 241 out of 4901 (4.9%)
PPCs. Because of a misunderstanding, five physicians
Table 1 Comparison of the
Sentinella versus Swiss Medical
Association (FMH) physician
collectives (MIPC study,
Switzerland 2015)
Parameter Sentinella collective 2015a FMH collective 2014
Number of physicians 180 6929
Gender
Male 71% 66%
Female 29% 34%
Age categories
\ 40 years 7% 9%
40–49 years 24% 25%
50–59 years 37% 34%
60 years and older 32% 32%
Specialty
GP 82% 86%
PED 18% 14%
aComparisons of Sentinella and Swiss Medical Association (FMH) groups by Chi square were not sig-
nificant. The two practices that did not report morbidity data were also included in this table, because they
were otherwise part of the Sentinella physician collective
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marked all patients known to the practices as follow-up
visits; their records were excluded (see above). In the GP
patient group, the mean patient age of records with a sec-
ond or further visit was one year older compared to those
visiting the practice only once (56.9 ± 21.7 vs.
55.8 ± 21.7 years, p = 0.042), whereas in PED practices
the opposite was the case (5.3 ± 5.6 vs. 6.1 ± 5.7 years,
p = 0.035). Gender distribution was not significantly dif-
ferent in follow-up compared to first visits (48.0 vs. 46.7%
males).
Age distribution of care dependency is depicted in
Fig. 3. Because our questionnaire did not offer the answer
‘‘care of minors by parents’’, this item was equivocal and
could not be evaluated in pediatric patients.
Correlations among measures of multimorbidity
and regional variation
The correlation matrix (Spearman’s Rho) revealed that all
variables (previous hospitalization, care dependency,
Fig. 1 Thurgau Morbidity
Index* (TMI) values, percent %
(MIPC study, Switzerland
2015). *The index values
denote: ‘‘0’’ healthy, ‘‘1’’
premorbid, ‘‘2’’ one or two
mild-to-moderate conditions,
‘‘3’’ three and more mild-to-
moderate conditions, ‘‘4’’ one
severe and less than three mild-
to-moderate conditions, ‘‘5’’ one
severe and three or more mild-
to-moderate conditions, ‘‘6’’
two or more severe conditions.
Graduations denote the entire
class
Fig. 2 Number of prescribed
drugs* regularly taken, percent
values (%) (MIPC study,
Switzerland 2015).
*Graduations denote the entire
class
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number of prescribed drugs regularly taken, number of
chronic diagnoses, TMI and Evans Index) were statistically
significantly correlated with each other. They also corre-
lated with age and—except for hospitalization—gender
(Table e5, Appendix E in Electronic Supplementary
Material). Compared to patients living in German or French
speaking regions, a statistically significantly lower mor-
bidity load of patients living in the Italian speaking region
was found. This applies to TMI, number of drugs, number
of conditions, and Evans’ Index (Figures e4 to e7, Appendix
E in Electronic Supplementary Material). However, the
sample size was small as expressed by the large error bars.
Discussion
We collected morbidity data in a primary care setting by
the Sentinella network with representative physician and
patient collectives in Switzerland (participation rate of
90%). In adult patients, we found a median TMI value of 3,
which means that half of the patients had at least three or
more chronic conditions of mild-to-moderate severity.
Similarly, half of the patients had three or more regular
drug treatments. Half of the patients over 80 years of age
were care dependent.
Thurgau Morbidity Index and Evans’ Index
In our study, the Thurgau Morbidity as well as the Evans’
indices increased with increasing age. The former index
was developed to predict cost in insurance collectives
(Fischer et al. 2007). The latter has shown to correlate with
survival in trauma patients (Evans et al. 2012; Holmes et al.
2014), in-hospital complications and the need for extended
care facilities (Justiniano et al. 2015), and re-admissions
(Housley et al. 2015). When coding TMI, the same con-
dition can have different impacts depending on whether the
condition is active or inactive, stable or unstable, or
Table 2 Logistic regression
using hospitalization in the
previous year as target variable
(odds ratios of adult patients
with complete records) (MIPC
study, Switzerland 2015)
Crude (mean, 95% CI) Adjustedc (mean, 95% CI)
Gendera 0.997 (0.904–1.055), p[ 0.05 0.908 (0.832–0.991), p = 0.030
Age (per year) 1.029 (1.027–1.032), p\ 0.001 0.994 (0.991–0.997), p\ 0.001
Conditions (per naming) 1.294 (1.274–1.315), p\ 0.001 1.038 (1.015–1.062), p = 0.001
Drugs (per naming) 1.244 (1.229–1.259), p\ 0.001 1.031 (1.011–1.050), p = 0.002
Thurgau Morbidity Index (per grade) 1.903 (1.849–1.958), p\ 0.001 1.650 (1.584–1.718), p\ 0.001
Care dependencyb by
Family/proxies 6.844 (5.914–7.920), p\ 0.001 2.875 (2.445–3.380), p\ 0.001
Community nurse 8.474 (7.196–9.979), p\ 0.001 3.219 (2.743–3.949), p\ 0.001
Institution/home 4.297 (3.725–4.958), p\ 0.001 1.515 (1.284–1.788), p\ 0.001
a(1 = male, 2 = female)
bCompared to none, n = 18,297
cAdjusted for all other variables in the table
Fig. 3 Care dependency* by
age groups (percent values %,
adult patients only) (MIPC
study, Switzerland 2015).
*Graduations denote the entire
class
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socially sensitive or non-sensitive. This aspect solves the
problem of diagnosis splitting of list-based indices (e.g.,
hypertension with or without end-organ damage), but
introduces subjectivity to the coding of TMI. On the one
hand, TMI does not differentiate between conditions of
mild and moderate degree. On the other hand, we did not
receive questions from the participating physicians con-
cerning the TMI (see Appendix C in Electronic Supple-
mentary Material). This leads to the conclusion that after
some training, TMI coding works easily and intuitively.
Although it may be easy to code TMI by the GPs, it may
not be appropriate for automated index construction from
existing databases. In contrast to an earlier study on Swiss
patients by Fischer et al. (2007), we found a shift of TMI
codes to the left side, indicating less morbidity (Figure e8,
Appendix E in Electronic Supplementary Material); how-
ever, that study did not include consecutive patients and
was designed to predict insurance costs which, therefore,
tended to include a more severely ill patient population
(Fischer 2016, personal communication). The lower TMI
and morbidity values of patients living in the Italian part of
Switzerland (Tessin) cannot be explained by our study
group; in the tables provided by the Swiss Federal Statis-
tical Office, there was a slightly higher life expectancy of
Tessin compared to Switzerland (males 80.7 vs. 80.2;
females 85.4 vs. 84.5 years), a higher mean age when
entering to a nursing home (83.0 vs. 81.5 years), and a
lower number of nursing home places (\ 40.0 vs. 64.5 per
1000 inhabitants) (FSO 2018).
Number of chronic conditions
We compared our data on morbidity with those from a
review by Fortin et al. (2012) which is suitable for com-
parisons with earlier European, Canadian and Australian
studies (Fig. 4). As expected, within our data set the TMI
coding of 3 and higher was slightly less frequent compared
to the reporting of three and more chronic conditions,
because the conditions count additionally included latent
and past diagnoses. The computer-based Swiss data by
Rizza et al. (2012) deriving from the FIRE project showed
a much lower rate of three and more conditions compared
to our study. This difference may be explained by the fact
that our data were consultation based, whereas the ones by
FIRE were registry based (ill patients have more visits than
healthy people). Furthermore, the FIRE physicians showed
significant underdiagnosing of common disorders (Zell-
weger et al. 2014); probably, this was less often the case in
our cross-sectional study, in which the physicians exten-
sively reviewed the patient records during a fortnight,
whereas the FIRE data reflect every day work that is
lacking such detailed review.
An overall population cohort study in the city of Lau-
sanne on self-reported and measured multimorbidity found
an overall prevalence of 23–56% depending on the defi-
nition used (Pache et al. 2015). In the same Sentinel system
as ours, Excoffier et al. (2017) found 35.0 (31.6–38.5)
chronic conditions. Guidelines provide recommendations
for patients with one single condition. However, multi-
morbidity is no exception in primary care (Treadwell
2015). Following guidelines developed for each single
condition in multimorbid patients may be complicated,
time consuming or even dangerous for patients and might
also lead to conflicts and more costs (Boyd et al. 2005;
Markun et al. 2014). In the same year 2015 Haller et al.
investigated the prevalence of multimorbidity in the Sen-
tinella patient collective and found a prevalence of 52.1%
for C 2 and 35.0% for C 3 chronic conditions, with no
significant gender differences (2018). The most prevalent
conditions were cardiovascular (42.7%), psychological
(28.5%), and metabolic or endocrine disorders (24.1%).
Number of drugs taken regularly
A Swiss study by a health insurance collective revealed
polypharmacy in 17% of the population, increasing to 50%
in very elderly (80? years) (Blozik et al. 2013). These
proportions are in line with those of the present study (20.7
and 60.9%, respectively). In contrast to an Italian study by
Nobili et al. (2009), who described a mean number of
2.4 ± 2.4 (± SD) prescribed drugs taken regularly by
patients aged 65 years and older in 2003, our patients of
this age group used, on average 4.9 ± 3.3 drugs. But there
were some differences in the definition of regular treat-
ments: in the work by Nobili, the cutoff was 12 months of
treatment, whereas in our study it was 1 month. In com-
parison to our study, Nobili excluded herbal medicines.
Furthermore, we included topical treatment with possible
systemic reactions. The Nobili data were registry based and
our data set was collected from PPCs visits. A Swedish
publication by Skoog et al. (2014) confirmed our obser-
vation that drug prescription increases with age, female
gender, and morbidity. In a Belgian cohort study with very
elderly (80? years) individuals, Wauters et al. (2016)
described a median number of five regularly used drugs. In
this study, the female gender, low education, moderate
alcohol consumption, multimorbidity, depression, and a
lack of physical activity were linked to polypharmacy. An
American study on patients at the time of hospital dis-
charge described an increased risk of polypharmacy ([ 16
drugs) in patients with two or more of the following high-
risk diagnoses: COPD, cancer, diabetes mellitus, conges-
tive heart failure, and coronary heart disease (Rohrer et al.
2013). The reduction in the proportion of young patients
with a single regular treatment from the first to the second
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decade (24 vs. 18%, Fig. 2) could possibly reflect the
vitamin D rickets prophylaxis of 0 to three-year-old infants.
We did not evaluate the appropriateness of medication in
our study patients. However, another study is now inves-
tigating the reduction of inappropriate medication in mul-
timorbid patients (Hasler et al. 2015). A recent Swedish
study by Rausch et al. (2017) reported the total number of
used drugs and inappropriate medication as associated with
hospitalizations for unintentional poisoning.
Hospitalization
We found that (previous) hospitalization was best predicted
by the TMI value, and somewhat less by the care-depen-
dency scale. However, TMI values were not independent of
the hospitalization status—a hospital stay can redefine a
given condition coding from mild/moderate to severe.
Therefore, the correlation observed in our study may reflect
an inverse causality, i.e., from the hospitalization to the
TMI. Interestingly, institutionalized patients had a lower
risk of being hospitalized as compared to people cared by
their family or proxies, as well as by the community nurse
(OR 6.8 and 8.5 vs. 4.3); this association also remained
statistically significant in the adjusted analysis. People
cared for by CNS are on risk for adverse drug reactions,
medication errors, and hospitalization (Eliot et al. 2016).
Although care by CNS may prevent the need for stationary
care (Markle-Reid et al. 2006), there might still be an
excessive need for it in CNS cared individuals compared to
nursing home-dwelling persons. In the case of acute illness,
this aspect could be explained by resilient caring networks
for institutionalized persons in comparison to people living
at home. Another explanation could be that caregivers were
more reluctant to hospitalize patients with progressing
disease status living in homes because no curative treat-
ment was possible and care could be delivered in the home,
as well.
Care dependency
The current report of the European Observatory on Health
Systems and Policies mentions that 4.2% of the Swiss
population receive professional long-term care; 64.0% of
them are at home and 36.0% in an institution. Additionally,
4.7% of the population (and 16.5% of those over 75 years)
receive care by their family or proxies, excluding persons
cared for by migrant workers (De Pietro et al. 2015). The
Swiss Federal Statistical Office data show that 1.5% of the
population of 65 and older lives in a nursing home (FSO
2018). The mean stay lasts for 2.5 years. The mean age of
entry to the home is 81.5 years.
Care dependency causes a lot of consequences, such as
loss of personal independency, a burden to the social net-
work, and financial demands (Ba¨hler et al. 2015; Jaspers
et al. 2015). An ongoing study investigated the disease and
treatment burden of Swiss primary care patients (De´ruaz-
Luyet et al. 2017). In a group of 888 multimorbid patients,
they found 5.5?2.2 chronic conditions and 7.7?3.5 pre-
scribed drugs. In our study, half of the patients in the age
group over 80 years were care dependent and almost half
Fig. 4 Comparison of Thurgau
Morbidity Index (C 3) or
chronic conditions (C 3) with
literaturea (Fortin et al. 2012,
see figure 3 of that article, with
permission) (MIPC study,
Switzerland 2015). aThis review
collected consultation-derived
information in primary care
settings from several studies and
compared the prevalence of
three or more chronic conditions
by age groups. However, the
Swiss FIRE data (Rizza et al.
2012) were not consultation- but
registry-based
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of the seniors over 90 years lived in homes for the elderly.
A substantial proportion of the care was delivered by
family and proxies as informal caregivers. In contrast to
other countries, in Switzerland more than half of the money
spent on care is covered by private expenditures irrespec-
tive of whether the care is carried out by professional or
informal caregivers (OECD 2011). This seems important as
care for inpatients living in homes for the elderly costs six
times more than care for outpatients (1.8% of gross
domestic product compared to 0.3%, respectively) (OECD
2011). This leads people in need to forego health care
services due to financial reasons (Bodenmann et al. 2015).
Strengths and limitations
The strengths of the study include a Swiss representative
sample of physicians and patients, data collection by
research-experienced physicians, as well as a large sample
size.
The possible weaknesses of our study are that we did not
have the opportunity to implement systematic data quality
control measures such as double entry or controls within
one physician. Furthermore, we did not assess specific
chronic conditions but used global measures of multimor-
bidity. The TMI is not validated as a measure of morbidity
and is prone to subjectivity in judgement of chronic con-
dition severity. However, this is a challenge for every
method that is used for the assessment of chronic condi-
tions and their severity. Another limitation is that certain
drugs taken by the patients but unreported to the physicians
could not be recorded. The fortnight study period (March)
cannot reflect seasonal changes (e.g., flu epidemic) so that
the results may be different over the course of a year.
Conclusion
In a representative sample of Swiss primary care patients, a
substantial part shows multimorbidity with a high preva-
lence of chronic diseases, multiple drug treatment, and care
dependency. These data may serve to be compared with
other patient groups or other primary care system.
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